These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 17495492

  • 1. Prostate cancer screening with prostate-specific antigen in hemodialysis patients.
    Horinaga M, Kitamura K, Saito S, Ukimura O, Nakanoma T, Okihara K, Kitagawa M, Nakanishi H, Miki T.
    Urol Int; 2007; 78(4):334-7. PubMed ID: 17495492
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk.
    Berger AP, Deibl M, Steiner H, Bektic J, Pelzer A, Spranger R, Klocker H, Bartsch G, Horninger W.
    Prostate; 2005 Aug 01; 64(3):240-5. PubMed ID: 15712213
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of total and free prostate specific antigen in men on hemodialysis.
    Sasagawa I, Kubota Y, Hayami S, Adachi M, Nakada T, Miura H, Imai K.
    J Urol; 1998 Jul 01; 160(1):83-5. PubMed ID: 9628610
    [Abstract] [Full Text] [Related]

  • 4. Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less.
    Ito K, Yamamoto T, Ohi M, Takechi H, Kurokawa K, Suzuki K, Yamanaka H.
    Prostate; 2003 Sep 15; 57(1):8-13. PubMed ID: 12886518
    [Abstract] [Full Text] [Related]

  • 5. Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project.
    Pelzer AE, Tewari A, Bektic J, Berger AP, Frauscher F, Bartsch G, Horninger W.
    Urology; 2005 Nov 15; 66(5):1029-33. PubMed ID: 16286118
    [Abstract] [Full Text] [Related]

  • 6. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
    Hosseini SY, Moharramzadeh M, Ghadian AR, Hooshyar H, Lashay AR, Safarinejad MR.
    Int J Urol; 2007 May 15; 14(5):406-11. PubMed ID: 17511722
    [Abstract] [Full Text] [Related]

  • 7. Mass screening for prostate cancer in patients with end-stage renal disease: a comparative study.
    Wada Y, Nakanishi J, Takahashi W, Kai N, Nakayama Y, Yamashita Y, Honda J, Ueda S.
    BJU Int; 2006 Oct 15; 98(4):794-7. PubMed ID: 16978274
    [Abstract] [Full Text] [Related]

  • 8. Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial.
    Crawford ED, Pinsky PF, Chia D, Kramer BS, Fagerstrom RM, Andriole G, Reding D, Gelmann EP, Levin DL, Gohagan JK.
    J Urol; 2006 Apr 15; 175(4):1286-90; discussion 1290. PubMed ID: 16515981
    [Abstract] [Full Text] [Related]

  • 9. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.
    Kumar R, Nayyar R, Kumar V, Gupta NP, Hemal AK, Jagannathan NR, Dattagupta S, Thulkar S.
    Urology; 2008 Oct 15; 72(4):859-63. PubMed ID: 18329078
    [Abstract] [Full Text] [Related]

  • 10. 4-year prostate specific antigen progression and diagnosis of prostate cancer in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.
    Schröder FH, Raaijmakers R, Postma R, van der Kwast TH, Roobol MJ.
    J Urol; 2005 Aug 15; 174(2):489-94; discussion 493-4. PubMed ID: 16006878
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer detection in men with a 'normal' total prostate-specific antigen (PSA) level using percentage free PSA: a prospective screening study.
    Rowe EW, Laniado ME, Walker MM, Patel A.
    BJU Int; 2005 Jun 15; 95(9):1249-52. PubMed ID: 15892810
    [Abstract] [Full Text] [Related]

  • 12. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG, Schwartz LM, Woloshin S.
    J Natl Cancer Inst; 2005 Aug 03; 97(15):1132-7. PubMed ID: 16077071
    [Abstract] [Full Text] [Related]

  • 13. Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan.
    Okihara K, Kitamura K, Okada K, Mikami K, Ukimura O, Miki T.
    Int J Urol; 2008 Feb 03; 15(2):156-60; discussion 161. PubMed ID: 18269453
    [Abstract] [Full Text] [Related]

  • 14. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M, Varedi P, Hosseini SJ, Asgari M, Shakiba M.
    Urol J; 2009 Feb 03; 6(3):182-8. PubMed ID: 19711272
    [Abstract] [Full Text] [Related]

  • 15. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Nanri M, Nanri K, Fujiyama C, Tokuda Y, Nakamura K, Uozumi J.
    Int J Urol; 2007 Jun 03; 14(6):505-9. PubMed ID: 17593094
    [Abstract] [Full Text] [Related]

  • 16. Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer.
    Berger AP, Deibl M, Strasak A, Bektic J, Pelzer AE, Klocker H, Steiner H, Fritsche G, Bartsch G, Horninger W.
    Urology; 2007 Jan 03; 69(1):134-8. PubMed ID: 17270635
    [Abstract] [Full Text] [Related]

  • 17. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S, Porter M.
    BJU Int; 2009 Nov 03; 104(10):1457-61. PubMed ID: 19522868
    [Abstract] [Full Text] [Related]

  • 18. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].
    Li M, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 01; 88(1):16-8. PubMed ID: 18346372
    [Abstract] [Full Text] [Related]

  • 19. Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.
    Pinsky PF, Andriole GL, Kramer BS, Hayes RB, Prorok PC, Gohagan JK, Prostate, Lung, Colorectal and Ovarian Project Team.
    J Urol; 2005 Mar 01; 173(3):746-50; discussion 750-1. PubMed ID: 15711261
    [Abstract] [Full Text] [Related]

  • 20. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.
    Seo HK, Chung MK, Ryu SB, Lee KH, Korean Urological Oncologic Society Prostate Cancer Study Group.
    Urology; 2007 Dec 01; 70(6):1109-12. PubMed ID: 18158028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.